This Vaccine Maker Can ‘Dominate’ The Covid Market For Years To Come, Wells Fargo Predicts

  • 📰 Forbes
  • ⏱ Reading Time:
  • 9 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 7%
  • Publisher: 53%

日本 ニュース ニュース

日本 最新ニュース,日本 見出し

Although its shares have lagged other vaccine makers in 2021, Pfizer could soon be poised for significant revenue growth.

Wall Street is underestimating vaccine maker Pfizer, which is primed for massive growth ahead as its Covid treatments will remain relevant for years—not to mention generate billions of dollars of revenue for the company, according to analysts at Wells Fargo.... [+]Wells Fargo recently initiated coverage of Pfizer with a “buy” rating and price target of $60 per share, implying an upside of around 16% from current levels.

Pfizer’s vaccine business alone could generate over $5 billion per year in revenue, the firm predicts, as COVID vaccines “will likely become an annual occurrence.”

 

コメントありがとうございます。コメントは審査後に公開されます。

I completely agree, COVID is the perfect business. The COVID investors have the Government and Social Media on their side; they keep redesigning their virus 🦠 and Terrorizing people all over the world 🌎 and legally supported against humanity just to make money 💰

このニュースをすぐに読めるように要約しました。ニュースに興味がある場合は、ここで全文を読むことができます。 続きを読む:

 /  🏆 394. in JP

日本 最新ニュース, 日本 見出し

Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。

GameStop, Stitch Fix, SentinelOne, Novavax: What to Watch When the Stock Market Opens TodayShares of Covid-19 vaccine makers were slipping; Earnings are due from GameStop. Muhammad Qasim has seen Prophet Muhammad SAW in great sadness and worry over the state of the Muslim ummah. Many events predicted in Qasim’s dreams about the future also correlate with the events of Hadith. Is Qasim the Imam Al-Mahdi?
ソース: WSJ - 🏆 98. / 63 続きを読む »